Neurotrope BioSciences

Obliterated by Alzheimer's failure, Neurotrope relinquishes its Nasdaq spot in reverse merger
Endpoints
Mon, 05/18/20 - 10:47 am
M&A
reverse merger
Neurotrope BioSciences
Metuchen
Petros